RAPT Therapeutics, Inc. (RAPT) Misses Q2 EPS by 56c

RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q2 EPS of ($0.65), $0.56 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• Jannik Sinner says he will not compete at US Open due to injury